Literature DB >> 16128778

Two-field lymph-node dissection may be enough to treat patients with submucosal squamous cell carcinoma of the thoracic esophagus.

T Nozoe1, Y Kakeji, H Baba, Y Maehara.   

Abstract

Significance of extended radical surgical treatment including three-field lymph node dissection for squamous cell carcinoma (SCC) of the esophagus remains debatable. The aim of the current study was to reconsider the merits and demerits obtained by three-field lymph node dissection for esophageal carcinoma and also to attempt to elucidate an appropriate surgical strategy for submucosal SCC of the thoracic esophagus. Thirty-one patients with SCC of the thoracic esophagus who had been treated with esophagectomy and two-field (thoracic and abdominal) lymph node dissection without preoperative therapies were enrolled. Five-year survival rate was 75.0% and the incidence proportion of postoperative complication was 9.7%. These data regarding postoperative outcome of patients were by no means inferior to those in the previous reports referring the prognosis of patients with esophageal carcinoma who had been treated with three-field lymph node dissection. Authors would like to mention that two-field lymph node dissection associated with reduced incidence of postoperative complications might be enough to treat the submucosal SCC of the thoracic esophagus.

Entities:  

Mesh:

Year:  2005        PMID: 16128778     DOI: 10.1111/j.1442-2050.2005.00482.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

Review 1.  Three-field lymph node dissection in esophageal cancer surgery.

Authors:  Satoru Matsuda; Hiroya Takeuchi; Hirofumi Kawakubo; Yuko Kitagawa
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Postoperative gastrointestinal dysfunction after 2-field versus 3-field lymph node dissection in patients with esophageal cancer.

Authors:  Misuzu Nakamura; Yoshihiro Kido; Yoshinori Hosoya; Masahiko Yano; Hideo Nagai; Morito Monden
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

3.  Impact of thoracic recurrent laryngeal node dissection: 508 patients with tri-incisional esophagectomy.

Authors:  Zihui Tan; Guowei Ma; Jinming Zhao; Amos Ela Bella; Tiehua Rong; Jianhua Fu; Yuqi Meng; Kongjia Luo; Dongrong Situ; Peng Lin
Journal:  J Gastrointest Surg       Date:  2013-11-16       Impact factor: 3.452

4.  Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification.

Authors:  Yuzhen Zheng; Zhen Wang; Feng Wang; Qingyuan Huang; Shuoyan Liu
Journal:  Oncotarget       Date:  2017-06-20

Review 5.  Past, present, and future of three-field lymphadenectomy for thoracic esophageal cancer.

Authors:  Harushi Udagawa
Journal:  Ann Gastroenterol Surg       Date:  2020-05-14

6.  FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.

Authors:  Zhaohua Xiao; Yang Jia; Wenpeng Jiang; Zhou Wang; Zhiping Zhang; Yanyun Gao
Journal:  Thorac Cancer       Date:  2018-06-06       Impact factor: 3.500

7.  Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma.

Authors:  Qilong Ma; Wengao Liu; Hao Long; Tiehua Rong; Lanjun Zhang; Yongbin Lin; Guowei Ma
Journal:  J Cardiothorac Surg       Date:  2015-09-18       Impact factor: 1.637

8.  Combined surgical treatment of esophageal cancer and coronary heart diseases in elderly patients.

Authors:  Weiran Zhang; Ban Liu; Yue Zhou; Feng Wang; Chang Gu; Qi Wang; Xiaofang Wang; Yangyang Zhang
Journal:  World J Surg Oncol       Date:  2018-10-24       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.